GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Falling Comet
2477.4000 13.10 (0.53%)
NSE Dec 29, 2025 15:31 PM
Volume: 51,186
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025
2477.40
0.53%
buy
by Motilal Oswal
Target: 3000 | Upside : 21.1%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors decreased from 390 to 362 in Sep 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Market closes lower, dragged down by foreign investor outflows and higher crude prices
Trendlyne Marketwatch | 29 Dec 2025, 04:01PM
Five Interesting Stocks Today - December 26, 2025
The Baseline | 26 Dec 2025